{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T07:59:37Z","timestamp":1768118377205,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.3816\/clm.2007.n.040","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:10:53Z","timestamp":1221095453000},"page":"541-545","source":"Crossref","is-referenced-by-count":27,"title":["Efficacy of Denileukin Diftitox in Subcutaneous Panniculitis-Like T-Cell Lymphoma"],"prefix":"10.3816","volume":"7","author":[{"given":"Tanya","family":"Hathaway","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Subtil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Foss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2007.n.040_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000478-199101000-00002","article-title":"T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome","volume":"15","author":"Gonzalez","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2007.n.040_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0959-8049(01)00344-6","article-title":"Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American Lymphoma (REAL) classification","volume":"38","author":"Kim","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.3816\/CLM.2007.n.040_bib3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/00000478-199807000-00010","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha\/beta and gamma\/delta subtypes","volume":"22","author":"Salhany","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2007.n.040_bib4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00000372-200106000-00008","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: an elusive case presenting as lipomembranous panniculitis and a review of 72 cases in the literature","volume":"23","author":"Weenig","year":"2001","journal-title":"Am J Dermatopathol"},{"key":"10.3816\/CLM.2007.n.040_bib5","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1365-2133.2005.06905.x","article-title":"The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants","volume":"153","author":"Slater","year":"2005","journal-title":"Br J Dermatol"},{"issue":"suppl 1","key":"10.3816\/CLM.2007.n.040_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.0303-6987.2006.00494.x","article-title":"Classification of cutaneous T-cell lymphoma: from Alibert to WHO-EORTC","volume":"33","author":"Willemze","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.3816\/CLM.2007.n.040_bib7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/cncr.11107","article-title":"Cytotoxic\/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop","volume":"97","author":"Santucci","year":"2003","journal-title":"Cancer"},{"key":"10.3816\/CLM.2007.n.040_bib8","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archderm.136.8.1024","article-title":"Gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study","volume":"136","author":"Toro","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.3816\/CLM.2007.n.040_bib9","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2007.n.040_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2141.2006.06457.x","article-title":"Phase II trial of denileukin diftitox for relapsed\/refractory T-cell non-Hodgkin lymphoma","volume":"136","author":"Dang","year":"2007","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2007.n.040_bib11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/archderm.138.6.740","article-title":"Denileukin diftitox for the treatment of panniculitic lymphoma","volume":"138","author":"McGinnis","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.3816\/CLM.2007.n.040_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1365-2133.2000.03671.x","article-title":"Aggressive subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine, mitoxantrone and dexamethasone","volume":"143","author":"Au","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.3816\/CLM.2007.n.040_bib13","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.bmt.1702064","article-title":"Effective CD34+ selected autologous peripheral blood stem cell transplantation in a patient with subcutaneous panniculitic T cell lymphoma (SPTCL) transformed into leukemia","volume":"24","author":"Hashimoto","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.3816\/CLM.2007.n.040_bib14","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0190-9622(97)80005-9","article-title":"Subcutaneous T-cell lymphoma treated with systemic chemotherapy, autologous stem cell support, and limb amputation","volume":"37","author":"Haycox","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2007.n.040_bib15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/mpo.1252","article-title":"Subcutaneous panniculitic T-cell lymphoma in childhood: successful response to chemotherapy","volume":"37","author":"Thomson","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.3816\/CLM.2007.n.040_bib16","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1084\/jem.167.2.612","article-title":"Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxinrelated interleukin 2 fusion protein","volume":"167","author":"Bacha","year":"1988","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2007.n.040_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3816\/CLM.2001.n.005","article-title":"Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication","volume":"1","author":"Foss","year":"2001","journal-title":"Clin Lymphoma"},{"key":"10.3816\/CLM.2007.n.040_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1200\/JCO.2001.19.2.376","article-title":"Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma","volume":"19","author":"Olsen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2007.n.040_bib19","doi-asserted-by":"crossref","first-page":"11885","DOI":"10.1016\/S0021-9258(19)38482-0","article-title":"Structure\/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells","volume":"265","author":"Williams","year":"1990","journal-title":"J Biol Chem"},{"key":"10.3816\/CLM.2007.n.040_bib20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.jid.5700122","article-title":"CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma","volume":"126","author":"Talpur","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2007.n.040_bib21","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1158\/1078-0432.CCR-0721-03","article-title":"Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy","volume":"10","author":"Jones","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLM.2007.n.040_bib22","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood-2004-11-4570","article-title":"A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma","volume":"106","author":"Foss","year":"2005","journal-title":"Blood"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011701044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011701044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T07:50:59Z","timestamp":1631778659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011701044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1557919011701044"],"URL":"https:\/\/doi.org\/10.3816\/clm.2007.n.040","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}